Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2006
11/02/2006EP1509215B1 Treatment or prevention of urogenital atrophy and its symptoms in women
11/02/2006EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006EP1315700B1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
11/02/2006EP0735883B1 Composition for contraception comprising an estrogen and a gestagen
11/02/2006CA2603807A1 Polymorph form ii of tanaproget
11/02/2006CA2603786A1 Purified form of tanaproget
11/01/2006CN1853726A Polymer system for improving insoluble medicine water solubility and preparation thereof
11/01/2006CN1853719A Pearl-layer hornshell hydrolytic protein drip balls and preparation thereof
11/01/2006CN1853683A Medicine for treating colpitis and preparation thereof
11/01/2006CN1853658A Use of glossy ganoderma spore powder for treating colpitis or cervicitis
11/01/2006CN1853632A Herba fibraurae recisae soft capsules and production thereof
11/01/2006CN1282487C Sustained release medicine for artificially inducing sex reversal of grouper and its preparation method
11/01/2006CN1282483C Slow-releasing oxytocic for artificial inducting maturation and ovulation and ejaculation rockfish and use
11/01/2006CN1282477C Chinese traditional medicine capable of warming kidney and invigorating yang
11/01/2006CN1282469C Chinese medicine for preventing hemolysis, preventing miscarriage and tonifying brain to prevent blood group incompatibility hemolysis disease in pregnancy
11/01/2006CN1282459C Progesterone capsule and preparing method thereof
10/2006
10/31/2006US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006US7129237 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride
10/31/2006US7129057 Human testis specific serine/threonine kinase 3
10/31/2006US7128932 Formulations useful in the treatment of male and female impotence
10/31/2006US7128930 Topically administering to the genitals of a patient with sexual dysfunction an ethyl ester of L-arginine, combination of ascorbic acid and ascorbic acid palmitate as antioxidants to cause the desired level of blood flow to erectile tissue while minimizing peroxynitrite levels
10/26/2006WO2006111856A1 Pyrazole derivatives as progesterone receptor antagonists
10/26/2006WO2006111546A1 Method for improving the fertility of animals
10/26/2006WO2002101008A3 Intracellular signaling molecules
10/26/2006US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006US20060241123 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
10/26/2006US20060241051 Metastin derivatives and use thereof
10/26/2006US20060240011 Use of nf-kappa b inhibitors for the treatment of mastitis
10/26/2006US20060240004 Methods for treating tweak-related conditions
10/26/2006US20060239993 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency
10/26/2006US20060239936 Delivery of anti-migraine compounds through an inhalation route
10/26/2006CA2604774A1 Method for improving the fertility of animals
10/26/2006CA2604218A1 Pyrazole derivatives as progesterone receptor antagonists
10/25/2006EP1714674A1 Method for improving the fertility of animals
10/25/2006EP1714658A1 Dietary supplement comprising antioxidant agents and carnitine or a precursor thereof, to be used as an aid to fertility in men and women
10/25/2006EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006EP1714643A1 Sustained release preparation
10/25/2006EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents
10/25/2006EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
10/25/2006EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
10/25/2006EP0827408B1 Method of administration of igf-i
10/25/2006CN1852911A Epimeridinoside A and epimeredi indica root extract preparation containing same and preparing method therefor
10/25/2006CN1852725A Extract of ogalpi, erectile dysfunction fanning healthy food and erectile dysfunction treating agent containing the same
10/25/2006CN1852704A Treatment of premature ejaculation
10/25/2006CN1850267A Ointment of treating dysmenorrhea, its preparing method and quality control method
10/25/2006CN1850253A Qianjin-Baoyun preparation and novel preparing method
10/25/2006CN1850248A Chinese medicine capsule for treating hyperplasia mammary glands and preparing method
10/25/2006CN1850247A Pure Chinese medicine for treating hyperplasia of mammary glands and preparing method
10/25/2006CN1850245A Medicine for treating sterility
10/25/2006CN1850234A Funingkang thin-coating tablet and preparing method
10/25/2006CN1850232A Gongxuening soft capsule, its preparing method and sue
10/25/2006CN1850229A Nushengjin preparation and new preparing method
10/25/2006CN1850226A Semifluid extract of deer foetus and preparing method
10/25/2006CN1850211A Tablet for treating impotence and its preparing technology
10/25/2006CN1850208A Quality control method for ass-skin glue blood-supplementing preparation
10/25/2006CN1850206A Medicine for treating women's climateric syndrome and preparing method
10/25/2006CN1850202A Vagina external-use medicine composition and its preparing method and use
10/25/2006CN1850189A Bonus syrup and its preparing technology
10/25/2006CN1850188A Bonus fluid extract and preparing method therefor
10/25/2006CN1850187A Bonus micro-pills and its preparing technology
10/25/2006CN1850179A Chinese medicine for treating women sterility and preparing method therefor
10/25/2006CN1850178A Method for preparing aconturm fischeri mankshood
10/25/2006CN1850174A Method for preparing Rhizoma cimicifugae formula granules
10/25/2006CN1850168A Water-lily-powder composition with function of compensating estrogen
10/25/2006CN1850159A Navel plastering piece for treating dysmenorrhea and preparing method
10/25/2006CN1850158A Tanshinoue dropping pills and preparing method
10/25/2006CN1850157A Health-care for resisting hyperplasia of mammary glands
10/25/2006CN1850155A Dispersible tablet of clinopodium polycephalum, and its preparing method
10/25/2006CN1850100A Medicinal composition for treating vagina disease
10/25/2006CN1850087A Effervescent tablet containing cefixime and its preparing method
10/25/2006CN1850076A Heat-sensitive gel containing matrine alkaloid and its preparing method
10/25/2006CN1850064A Preparation for relieving stress symptom
10/25/2006CN1850034A Polyurethane contraceptive stopping suppository
10/25/2006CN1281608C New azo-indolyl derivatives
10/25/2006CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006CN1281272C Interferon effervescence capsule for vagina used and its preparation method
10/25/2006CN1281265C Diuretic and menstruation-regulating medicine and its prepn
10/25/2006CN1281262C Chinese medicine for gynaecological tumor and preparation method
10/25/2006CN1281249C Method of preparing compound Chinese traditional medicine for treating endometriosis and secondary dysmenorrhea
10/25/2006CN1281248C Compound Chinese traditional medicine for treating endometriosis and secondary dysmenorrhea
10/25/2006CN1281245C Medicine for treating asynodia and prospermia
10/25/2006CN1281228C Medicine for hyperplasia of mammary glands and its preparation
10/25/2006CN1281222C Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
10/24/2006US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006US7125970 Host cells; drug screening; antigrowth agents
10/24/2006US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes